Cortexyme, Inc.
Records under this name other than patents Cortexyme, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Cortexyme, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,988,375 | Inhibitors of Lysine Gingipain Formerly held In force · High confidence | In force | High confidence | |
| US 10,301,301 | Inhibitors of Lysine Gingipain Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,332,464 | Inhibitors of Lysine Gingipain Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,758,473 | Inhibitors of Lysine Gingipain Formerly held In force · High confidence | In force | High confidence | |
| US 10,730,826 | Ketone Inhibitors of Lysine Gingipain Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,325,884 | Ketone Inhibitors of Lysine Gingipain Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,110,263 | Ketone Inhibitors of Lysine Gingipain Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,059,786 | Aminopyridine compounds and methods for the preparation and use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,906,881 | Inhibitors of Arginine Gingipain Formerly held Lapsed on the fee record Ended Feb 2, 2025 · High confidence | Lapsed on the fee record | Ended Feb 2, 2025 | High confidence |
| US 10,676,470 | Inhibitors of Lysine Gingipain Formerly held Lapsed on the fee record Ended Jun 9, 2024 · Medium confidence | Lapsed on the fee record | Ended Jun 9, 2024 | Medium confidence |